HAIR FOLLICLE TUMOUR BENIGN

This adverse event was reported 111 times

These drugs are most commonly taken by patients reporting HAIR FOLLICLE TUMOUR BENIGN:

# Drug Count
0 AZATHIOPRINE 46
1 METHOTREXATE SODIUM 46
2 LEFLUNOMIDE 43
3 ACETAZOLAMIDE 41
4 ACETAZOLAMIDE SODIUM 41
5 ALENDRONATE SODIUM 41
6 METHOTREXATE 39
7 INFLIXIMAB 35
8 PREDNISONE 31
9 CYCLOPHOSPHAMIDE 27
See all common drugs associated with HAIR FOLLICLE TUMOUR BENIGN

HAIR FOLLICLE TUMOUR BENIGN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACETAZOLAMIDE SODIUM 41 0.0067
1 ALCLOMETASONE DIPROPIONATE 1 0.0032
2 ERYTHROMYCIN ETHYLSUCCINATE 1 0.0016
3 ANAKINRA 15 0.0009
4 METHYLPHENIDATE HCL 1 0.0008
5 AMPICILLIN SODIUM AND SULBACTAM SODIUM 2 0.0008
6 CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 1 0.0005
7 AZATHIOPRINE 46 0.0005
8 TESTOSTERONE 12 0.0005
9 ALENDRONATE SODIUM TABLET 8 0.0004
See all drugs enriched for association with HAIR FOLLICLE TUMOUR BENIGN

HAIR FOLLICLE TUMOUR BENIGN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Carbonic Anhydrase Inhibitor [EPC] 41 0.0020
1 Interleukin-1 Receptor Antagonist [EPC] 15 0.0009
2 Purine Antimetabolite [EPC] 46 0.0005
3 Androgen [EPC] 12 0.0004
4 Antirheumatic Agent [EPC] 43 0.0004
5 Antiseptic [EPC] 1 0.0002
6 Hedgehog Pathway Inhibitor [EPC] 2 0.0002
7 Topoisomerase Inhibitor [EPC] 16 0.0002
8 Recombinant Human Growth Hormone [EPC] 4 0.0002
9 Calcium [EPC] 25 0.0002
See all drug classes enriched for association with HAIR FOLLICLE TUMOUR BENIGN